IL6-receptor antibody tocilizumab as salvage therapy in severe chronic graft-versus-host disease after allogeneic hematopoietic stem cell transplantation: a retrospective analysis

Chronic graft-versus-host disease (cGvHD) remains the most relevant factor affecting survival after allogeneic hematopoietic stem cell transplantation (alloHSCT). Besides corticosteroids (and ibrutinib in the USA), there is no established therapy for cGvHD. Tocilizumab, a humanized IgG1 IL6-receptor...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
izdano v:Ann Hematol
Main Authors: Kattner, Anna-Sophia, Holler, Ernst, Holler, Barbara, Klobuch, Sebastian, Weber, Daniela, Martinovic, Danilo, Edinger, Matthias, Herr, Wolfgang, Wolff, Daniel
Format: Artigo
Jezik:Inglês
Izdano: Springer Berlin Heidelberg 2020
Teme:
Original Article
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC7069928/
https://ncbi.nlm.nih.gov/pubmed/32086584
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s00277-020-03968-w
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki